News
Myriad Genetics posted Q2 revenue growth of 1% year-over-year, but adjusted for one-time events, growth would have been 5%.
Discover the facts about CLOVES syndrome—an extremely rare genetic disorder with complex symptoms and challenging diagnosis.
Currently, GenAns Biotech is conducting investigator-initiated trials for several gene therapies, including GA001 for ...
Th<span id="cke_bm_479S" style="display:no is study aimed to bridge that gap by conducting genetic analysis on a cohort of ...
Following a tragic fire that killed chained inmates in a nearby facility, a Tamil Nadu dargah evolves a new model of mental ...
A global study has identified the DNA markers for stuttering, providing a genetic link that will pave the way for clinicians ...
Molecular testing in dermatology involves decisions about who gets tested, how to test and interpret results, and where to go ...
Recent advancements in genomic technologies have greatly advanced our understanding of genomic regions implicated in disease processes, including ...
Columnist Joe MacDonald, who has essential tremors, shares with his sons the feeling of having a sometimes visible disorder.
WellSpan is among 15 health care organizations participating in the project that tailors care for people who are found to be at high risk for cancers and heart disease.
A global study has identified the DNA markers for stuttering, providing a genetic link that will pave the way for clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results